Security Snapshot

Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) Institutional Ownership

CUSIP: 09075F404

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

29

Shares (Excl. Options)

885,150

Price

$1.53

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
BNGO on Nasdaq
Shares outstanding
11,229,947
Price per share
$1.12
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
885,150
Total reported value
$1,354,477
% of total 13F portfolios
0%
Share change
+640,747
Value change
+$972,920
Number of holders
29
Price from insider filings
$1.12
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • BNGO - Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 09075F404.
  • 29 institutions reported positions in Q4 2025.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 29 to 29 between Q3 2025 and Q4 2025.
  • Reported value moved from $417,230 to $1,354,477.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Form 13F

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP 09075F404?
CUSIP 09075F404 identifies BNGO - Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 9.9% 0% $1,795,763 +$171,307 1,129,411 +11% CVI Investments, Inc. 31 Dec 2025
Lind Global Fund III LP 9.4% -5.5% $1,669,500 +$851,703 1,050,000 +104% Lind Global Fund III LP 31 Dec 2025
Ayrton Capital LLC 10% $903,140 528,245 Ayrton Capital LLC 30 Sep 2025
Lincoln Alternative Strategies LLC 5.4% $2,021,250 525,000 Lincoln Alternative Strategies LLC 17 Sep 2025
Iroquois Capital Management, LLC 5% -8.2% $871,362 -$26,230 509,658 -2.9% Iroquois Capital Management, LLC 30 Sep 2025
INTRACOASTAL CAPITAL, LLC 5% $1,957,398 508,415 Mitchell P. Kopin 16 Sep 2025

As of 31 Dec 2025, 29 institutional investors reported holding 885,150 shares of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO). This represents 7.9% of the company’s total 11,229,947 outstanding shares.

Institutional Holders of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 885,150 $1,354,477 +$972,920 $1.53 29
2025 Q3 244,406 $417,230 +$180,899 $1.71 29
2025 Q2 100,433 $328,973 +$12,075 $3.28 25
2025 Q1 104,118 $290,503 +$210,076 $2.79 27
2024 Q4 198,732 $57,021 +$54,382 $0.29 5

Sponsored